Early- to mid-term outcome of a short, cementless, titanium, flat, tapered stem for primary total hip arthroplasty: an independent series.

Jonathan Bourget-MurrayBrook BiniamRaman S BhullarPaul KimWade GoftonPaul E BeauléGeorge Grammatopoulos

Published in: Hip international : the journal of clinical and experimental research on hip pathology and therapy (2023)

The 7-year survivorship of the Taperloc Microplasty stem is within National Institute for Health and Care Excellence (NICE) guidelines. Patients ⩽65 years with osteoarthritis and Dorr A/B femoral morphology may be ideal candidates for THA with this stem. Femoral remodelling is common and not associated with adverse outcome.

Keyphrases

total hip arthroplasty
healthcare
end stage renal disease
newly diagnosed
ejection fraction
quality improvement
public health
total knee arthroplasty
palliative care
mental health
emergency department
risk assessment
patient reported outcomes
health information
young adults
chronic pain
human health